Skip to main content
OpenTrials
Completed

NCT Number: NCT01380470

Prevalence of Undiagnosed Chronic Obstructive Pulmonary Disease Sufferers in the Region of Murcia

The purpose of this study is determine the prevalence of undiagnosed Chronic Obstructive Pulmonary Disease (COPD) in population served and with exposure to cigarettes in the Region of Murcia

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Fundación para la Formación e Investigación Sanitarias de la Región de Murcia

Murcia, 30003, Spain

About this study

COPD is a serious, chronic and very disabling, associated with smoking and aging. Therefore it is a preventable and treatable process. It is know to be a pathology under diagnosed and when diagnosis, this is done in advanced stage, resulting to rise to more complication and more severe, in a addition to a high social and economic cost.

Therefore, take out an epidemiological study, observational, multicentre, whose main objective is estimate the prevalence of undiagnosed COPD in population served between 40 and 70 years and exposure to cigarettes in the Region of Murcia.

Other objectives are estimate the proportion of patients already diagnosed, identifying risk factors associated with not previous diagnosis of COPD and describe the history of symptoms in them. Description of therapeutic manage and motivation to give up smoking.

The study was carried out with 120 researcher doctors and 120 researcher nurses from 40 health centers in the Region of Murcia.

Each researcher will select 10 patients for the main objective and 10 for objectives related to manage of COPD.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged between 40 and 70 years of both sexes
  • With a history of smoking (current or past)
  • Do not diagnosed with COPD at the time of completion of study

Exclusion criteria

  • Prior diagnosis of COPD or Asthma
  • A condition prevents performing spirometry
  • Patients displaced

For those diagnosed with COPD:

Inclusion criteria

  • Subject treated in CS there is explicit evidence for the disease

Exclusion criteria

  • Subjects who at the time of the consultation arouse suspicion of previously undiagnosed COPD

Treatment and study plan

Primary outcomes

  1. FEV1/FVC,Forced Expiratory Volume 1/ Forced Vital Capacity

    Time frame: 15 days

Sponsors and collaborators

Lead sponsor

Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia

Other

Collaborators

  • AstraZeneca
  • MurciaSalud
  • Public Health Service, Murcia

Registry information

Official study title

Prevalence of Undiagnosed Sufferers in Murcia :Cross-sectional Study

Important dates

Study start
2010
Primary completion
2010
Study completion
2010
First posted
Jun 27, 2011
Registry last updated
Dec 15, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.